Latest news with #WillLee
Business Wire
9 hours ago
- Business
- Business Wire
ADWEEK and ProRata Bring AI-Powered Answers to ADWEEK.com
LOS ANGELES & NEW YORK--(BUSINESS WIRE)-- ('ProRata'), creator of the AI-powered Gist Answers platform, and ADWEEK, a leading voice in advertising, marketing, and media, today announced the integration of Gist Answers across ADWEEK's digital properties, including and the Cannes Lions Digital Companion. Through this partnership, ADWEEK will offer readers AI-powered search, article summaries, and context-aware answers—all designed to enhance engagement and surface authoritative insights. Exciting partnership! @ProRataAI has teamed up with @Adweek to integrate Gist Answers AI platform, bringing readers powerful search capabilities, intelligent summaries, and context-aware insights. #canneslions #Gistai Share 'As the front page and home page of the marketing, advertising and media industry, we're excited to be the first to offer this enhanced AI experience to our audience,' said Will Lee, CEO of ADWEEK. 'With Gist Answers, we can combine our award-winning journalism with trusted external sources to deliver deeper context and smarter discovery in response to user questions.' Gist Answers is purpose-built for publishers, enabling them to deploy a branded 'AI companion' on their sites. It enriches a publisher's proprietary content with fully-licensed, high-quality material from hundreds of trusted publications, delivering relevant, reliable information while keeping the spotlight on the publisher's original reporting. The platform is fully ad-supported and available to publishers at no cost. 'Publishers shouldn't have to choose between reach and control,' said Annelies Jansen, Chief Business Officer at 'Gist Answers lets them enhance their own content with AI-powered tools—without sacrificing editorial integrity or losing readers to search engines that don't credit the source.' This collaboration addresses the growing demand for ethical, trustworthy generative AI while giving publishers a powerful tool to retain audiences, increase engagement, and build trust through credible, AI-enhanced experiences. About ADWEEK ADWEEK is the leading source of news, insight and intelligence powering and empowering advertising, marketing, and growth. For more than 45 years, ADWEEK's award-winning coverage reaches an engaged community across digital, events, podcasts, newsletters, print, and social media. As a touchstone of the advertising and marketing community, ADWEEK is an unparalleled resource for leaders across multiple industries who rely on its content to give them a competitive advantage. About Founded in 2024 by Bill Gross, ProRata develops ethical AI solutions that ensure content owners are credited and compensated for the use of their work. The company's leadership includes former executives and engineers from Microsoft, Google, and Meta. ProRata is backed by, among others, Mayfield Fund, Revolution Ventures, Prime Movers Lab, dmg media, BOLD Capital, XPV-Exponential Ventures, Calibrate Ventures, MVP Ventures, and Idealab Studio. Learn more at
Yahoo
13 hours ago
- Business
- Yahoo
ADWEEK and ProRata Bring AI-Powered Answers to ADWEEK.com
LOS ANGELES & NEW YORK, June 17, 2025--(BUSINESS WIRE)-- ("ProRata"), creator of the AI-powered Gist Answers platform, and ADWEEK, a leading voice in advertising, marketing, and media, today announced the integration of Gist Answers across ADWEEK's digital properties, including and the Cannes Lions Digital Companion. Through this partnership, ADWEEK will offer readers AI-powered search, article summaries, and context-aware answers—all designed to enhance engagement and surface authoritative insights. "As the front page and home page of the marketing, advertising and media industry, we're excited to be the first to offer this enhanced AI experience to our audience," said Will Lee, CEO of ADWEEK. "With Gist Answers, we can combine our award-winning journalism with trusted external sources to deliver deeper context and smarter discovery in response to user questions." Gist Answers is purpose-built for publishers, enabling them to deploy a branded "AI companion" on their sites. It enriches a publisher's proprietary content with fully-licensed, high-quality material from hundreds of trusted publications, delivering relevant, reliable information while keeping the spotlight on the publisher's original reporting. The platform is fully ad-supported and available to publishers at no cost. "Publishers shouldn't have to choose between reach and control," said Annelies Jansen, Chief Business Officer at "Gist Answers lets them enhance their own content with AI-powered tools—without sacrificing editorial integrity or losing readers to search engines that don't credit the source." This collaboration addresses the growing demand for ethical, trustworthy generative AI while giving publishers a powerful tool to retain audiences, increase engagement, and build trust through credible, AI-enhanced experiences. About ADWEEK ADWEEK is the leading source of news, insight and intelligence powering and empowering advertising, marketing, and growth. For more than 45 years, ADWEEK's award-winning coverage reaches an engaged community across digital, events, podcasts, newsletters, print, and social media. As a touchstone of the advertising and marketing community, ADWEEK is an unparalleled resource for leaders across multiple industries who rely on its content to give them a competitive advantage. About Founded in 2024 by Bill Gross, ProRata develops ethical AI solutions that ensure content owners are credited and compensated for the use of their work. The company's leadership includes former executives and engineers from Microsoft, Google, and Meta. ProRata is backed by, among others, Mayfield Fund, Revolution Ventures, Prime Movers Lab, dmg media, BOLD Capital, XPV-Exponential Ventures, Calibrate Ventures, MVP Ventures, and Idealab Studio. Learn more at View source version on Contacts Media contacts: ADWEEK Julie Farinjulie@ David Shanemedia@
Yahoo
29-05-2025
- Business
- Yahoo
Helix releases pharmacogenomics tests for use in neurology and oncology
US-based genomics company Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio to offer personalised patient care in neurology and oncology. The suite includes a PGx Fluoropyrimidines DPYD test to detect individuals with dihydropyrimidine dehydrogenase (DPYD) gene variants at risk for side effects from certain chemotherapies, aligning with the recent guidelines from the National Comprehensive Cancer Network. The DPYD test provides insights into a patient's metabolism of cancer treatments. It targets therapies used in treating breast, pancreatic, head and neck, colorectal, and oesophageal cancers. Additionally, the suite includes the PGx APOE test to evaluate the status of apolipoprotein E (APOE) relevant to Alzheimer's drugs. It assesses the risk of serious adverse effects such as amyloid-related imaging abnormalities (ARIA) for individuals treated with Leqembi or Kisunla. These drugs have US Food and Drug Administration (FDA) boxed warnings for individuals with two copies of the APOE ε4 allele. With these tests, Helix now covers all neurology and oncology-associated PGx haplotypes cited in the agency's warnings. The company noted that its PGx tests offer accuracy across varied populations, utilising its Exome+ assay and comprehensive star allele caller. Its Sequence Once, Query Often model allows for exomes to be sequenced just once, with subsequent genetic tests not requiring additional samples. This facilitates rapid results, enabling genetic insights at the point of care. Helix's latest PGx tests encompass medications for cancer, cardiovascular diseases, pain management, gastrointestinal conditions, and anaesthesia guidance. These tests add to the company's existing PGx offerings for blood clotting, mental health, and immune suppression treatments. In addition, Helix has also developed the Helix Research Network in collaboration with its partners. This precision clinical research network comprises health systems focused on integrating genomics into routine care and advancing human health through genomics research. It also creates real-world evidence to support a wide range of initiatives, including studies showing the genomics' clinical use. Helix chief science officer Will Lee said: 'By focusing on patients with neurodegenerative conditions and cancer, and actively identifying those at higher risk for adverse outcomes, we can help providers treat vulnerable patients more precisely and effectively.' "Helix releases pharmacogenomics tests for use in neurology and oncology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
20-04-2025
- Sport
- USA Today
'We have two 'blankets' now' Texas A&M CB Will Lee III speaks on transfer Julian Humphrey
'We have two 'blankets' now' Texas A&M CB Will Lee III speaks on transfer Julian Humphrey The 2025 Texas A&M Maroon & White Spring game answered many early questions about the defensive side of the ball. The team made plays on all three levels, limited the big plays, and caused several turnovers while looking in midseason form. At the end of last season, coach Mike Elko made headlines for being upset about his team's inability to stop pass plays during the bowl game against a depleted USC Trojan football team. He took full responsibility for not having his team ready to play and said he would get more involved in the defense. However, he didn't just talk about it; he attacked it head-on, hitting the transfer portal and adding to his staff. The Aggies got a head start on shoring up the cornerback position when Will Lee announced that he was returning for his senior season, but that still left a void when it came to experienced players who had success at a high level. A&M veteran Tyreek Chappell spent most of his time on the injured reserve list, and the talented Dezz Ricks struggled down the stretch. Coach Elko brought some competition to the position when he picked up transfers Jordan Shaw from Washington and Julian Humphrey from Georgia. After getting rave reviews during spring practice, they put in some solid work during the spring game. Will Lee spoke on the defensive backs after the game. "Jordan Shaw specifically like he's a dog. That's really been like a person I always felt close with since he came in. He's an open guy you can talk to him all day every day about anything and on the field, he knows what he's doing he's playing fast" "Julio he's making great plays out there on the field and he's going to keep balling. So we got two blankets now so we going to put it to work" The defensive back room now has depth and talent that have been working hard. Will Lee has confidence that they will be back on track and much improved, easing coach Elko's concerns from the end of last season. Contact/Follow us @AggiesWire on X and like our page on Facebook to follow ongoing coverage of Texas A&M news, notes, and opinions. Follow Jarrett Johnson on X: @whosnextsports1.
